186 related articles for article (PubMed ID: 25519724)
41. Release of fatty acid amides in a patient with hemispheric stroke: a microdialysis study.
Schäbitz WR; Giuffrida A; Berger C; Aschoff A; Schwaninger M; Schwab S; Piomelli D
Stroke; 2002 Aug; 33(8):2112-4. PubMed ID: 12154273
[TBL] [Abstract][Full Text] [Related]
42. Changes in endocannabinoid and N-acylethanolamine levels in rat brain structures following cocaine self-administration and extinction training.
Bystrowska B; Smaga I; Frankowska M; Filip M
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():1-10. PubMed ID: 24334211
[TBL] [Abstract][Full Text] [Related]
43. Targeted stable-isotope dilution GC-MS/MS analysis of the endocannabinoid anandamide and other fatty acid ethanol amides in human plasma.
Zoerner AA; Gutzki FM; Suchy MT; Beckmann B; Engeli S; Jordan J; Tsikas D
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(26):2909-23. PubMed ID: 19414283
[TBL] [Abstract][Full Text] [Related]
44. Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies.
Vázquez C; Tolón RM; Pazos MR; Moreno M; Koester EC; Cravatt BF; Hillard CJ; Romero J
Neurobiol Dis; 2015 Jul; 79():41-50. PubMed ID: 25917763
[TBL] [Abstract][Full Text] [Related]
45. Prediction of preterm labour from a single blood test: The role of the endocannabinoid system in predicting preterm birth in high-risk women.
Bachkangi P; Taylor AH; Bari M; Maccarrone M; Konje JC
Eur J Obstet Gynecol Reprod Biol; 2019 Dec; 243():1-6. PubMed ID: 31618675
[TBL] [Abstract][Full Text] [Related]
46. Responses of peripheral endocannabinoids and endocannabinoid-related compounds to hedonic eating in obesity.
Monteleone AM; Di Marzo V; Monteleone P; Dalle Grave R; Aveta T; Ghoch ME; Piscitelli F; Volpe U; Calugi S; Maj M
Eur J Nutr; 2016 Jun; 55(4):1799-805. PubMed ID: 26759262
[TBL] [Abstract][Full Text] [Related]
47. Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channels in a receptor-independent manner.
Amorós I; Barana A; Caballero R; Gómez R; Osuna L; Lillo MP; Tamargo J; Delpón E
J Mol Cell Cardiol; 2010 Jan; 48(1):201-10. PubMed ID: 19616555
[TBL] [Abstract][Full Text] [Related]
48. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina.
Bisogno T; Delton-Vandenbroucke I; Milone A; Lagarde M; Di Marzo V
Arch Biochem Biophys; 1999 Oct; 370(2):300-7. PubMed ID: 10577359
[TBL] [Abstract][Full Text] [Related]
49. Troubleshooting in LC-MS/MS method for determining endocannabinoid and endocannabinoid-like molecules in rat brain structures applied to assessing the brain endocannabinoid/endovanilloid system significance.
Bystrowska B; Smaga I; Tyszka-Czochara M; Filip M
Toxicol Mech Methods; 2014 May; 24(4):315-22. PubMed ID: 24576199
[TBL] [Abstract][Full Text] [Related]
50. Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 receptors located on glutamatergic neurons and on astrocytes.
Belluomo I; Matias I; Pernègre C; Marsicano G; Chaouloff F
J Neurochem; 2015 Apr; 133(1):26-37. PubMed ID: 25626460
[TBL] [Abstract][Full Text] [Related]
51. Simultaneous determination of 2-arachidonoylglycerol, 1-arachidonoylglycerol and arachidonic acid in mouse brain tissue using liquid chromatography/tandem mass spectrometry.
Zhang MY; Gao Y; Btesh J; Kagan N; Kerns E; Samad TA; Chanda PK
J Mass Spectrom; 2010 Feb; 45(2):167-77. PubMed ID: 19950120
[TBL] [Abstract][Full Text] [Related]
52. Serum endocannabinoids in assessing pain in patients with chronic pancreatitis and in those with pancreatic ductal adenocarcinoma.
Pezzilli R; Ciuffreda P; Ottria R; Ravelli A; Melzi d'Eril G; Barassi A
Scand J Gastroenterol; 2017 Oct; 52(10):1133-1139. PubMed ID: 28631495
[TBL] [Abstract][Full Text] [Related]
53. Lipidomic Analysis of Endocannabinoid Signaling: Targeted Metabolite Identification and Quantification.
Keereetaweep J; Chapman KD
Neural Plast; 2016; 2016():2426398. PubMed ID: 26839710
[TBL] [Abstract][Full Text] [Related]
54. Fatty acid amide hydrolase inhibitors--progress and potential.
Khanna IK; Alexander CW
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):545-58. PubMed ID: 21631410
[TBL] [Abstract][Full Text] [Related]
55. Finding of endocannabinoids in human eye tissues: implications for glaucoma.
Chen J; Matias I; Dinh T; Lu T; Venezia S; Nieves A; Woodward DF; Di Marzo V
Biochem Biophys Res Commun; 2005 May; 330(4):1062-7. PubMed ID: 15823551
[TBL] [Abstract][Full Text] [Related]
56. Oxyhomologues of anandamide and related endolipids: chemoselective synthesis and biological activity.
Appendino G; Minassi A; Berton L; Moriello AS; Cascio MG; De Petrocellis L; Di Marzo V
J Med Chem; 2006 Apr; 49(7):2333-8. PubMed ID: 16570929
[TBL] [Abstract][Full Text] [Related]
57. Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications.
Bisogno T; De Petrocellis L; Di Marzo V
Curr Pharm Des; 2002; 8(7):533-47. PubMed ID: 11945157
[TBL] [Abstract][Full Text] [Related]
58. Simultaneous ultra-high performance liquid chromathograpy-electrospray ionization-quadrupole-time of flight mass spectrometry quantification of endogenous anandamide and related N-acylethanolamides in bio-matrices.
Ottria R; Ravelli A; Gigli F; Ciuffreda P
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 May; 958():83-9. PubMed ID: 24705535
[TBL] [Abstract][Full Text] [Related]
59. Circulating endocannabinoids in insulin sensitive vs. insulin resistant obese postmenopausal women. A MONET group study.
Abdulnour J; Yasari S; Rabasa-Lhoret R; Faraj M; Petrosino S; Piscitelli F; Prud' Homme D; Di Marzo V
Obesity (Silver Spring); 2014 Jan; 22(1):211-6. PubMed ID: 23616305
[TBL] [Abstract][Full Text] [Related]
60. Presence and regulation of the endocannabinoid system in human dendritic cells.
Matias I; Pochard P; Orlando P; Salzet M; Pestel J; Di Marzo V
Eur J Biochem; 2002 Aug; 269(15):3771-8. PubMed ID: 12153574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
